On the effect of xenin and xenin fragments on exocrine pancreas secretion in vivo.
A stimulatory effect on exocrine pancreas secretion could be demonstrated with high concentrations of the 25-amino-acid peptide xenin in non-anesthetized dogs. This peptide has been isolated from gastric mucosa and it is part of a structural coat protein. It has close structural similarities to neurotensin. The longer C-terminal fragments xenin-(13--25) and xenin-(18--25) are essential for the stimulation of exocrine pancreas secretion in vivo. The smaller peptide fragments xenin-(21--25) and xenin-(22--25) failed to stimulate the pancreas as well as the N-terminal peptide fragment xenin-(1--23). The stimulatory effects of xenin may be mediated via neural neurotensin pathways, because neurotensin receptor blockade abolished the stimulatory effect on pancreatic secretion. Cholinergic pathways are not involved, because atropine had no inhibiting effect.
Nustede
R
R
Department of General Surgery, Georg-August-University, Göttingen, Germany.
Schmidt
W E
WE
Horstmann
O
O
Sikovec
N
N
Schemminger
R
R
Becker
H
H
D000759:Adjuvants, Anesthesia / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005402:Fistula / Q000601:surgery; D005768:Gastrointestinal Hormones / Q000378:metabolism / Q000494:pharmacology*; D007275:Injections, Intravenous; D009496:Neurotensin; D010179:Pancreas / Q000187:drug effects* / Q000378:metabolism*; D010446:Peptide Fragments / Q000494:pharmacology*; D010455:Peptides / Q000378:metabolism / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D018028:Receptors, Neurotensin / Q000037:antagonists & inhibitors / Q000378:metabolism
D000759:Adjuvants, Anesthesia; D005768:Gastrointestinal Hormones; D010446:Peptide Fragments; D010455:Peptides; D011720:Pyrazoles; D011804:Quinolines; D018028:Receptors, Neurotensin; C077659:xenin 25; C079087:SR 48692; D009496:Neurotensin; D001285:Atropine